Adenosine and its receptors as therapeutic targets: An overview
Open Access
- 22 June 2012
- journal article
- review article
- Published by Elsevier BV in Saudi Pharmaceutical Journal
- Vol. 21 (3), 245-253
- https://doi.org/10.1016/j.jsps.2012.05.011
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Adenosine hypothesis of schizophrenia – Opportunities for pharmacotherapyNeuropharmacology, 2012
- Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive ratsPharmacological Research, 2012
- Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's diseasePharmacology & Therapeutics, 2011
- Structure-Based Discovery of A2AAdenosine Receptor LigandsJournal of Medicinal Chemistry, 2010
- The adenosinergic immunomodulatory drugsCurrent Opinion in Pharmacology, 2009
- Adenosine signaling and the regulation of chronic lung diseasePharmacology & Therapeutics, 2009
- Allosteric modulation of adenosine receptorsPurinergic Signalling, 2008
- Adenosine A2A receptors in Parkinson’s disease treatmentPurinergic Signalling, 2008
- Shaping of monocyte and macrophage function by adenosine receptorsPharmacology & Therapeutics, 2007
- The A2B adenosine receptor protects against inflammation and excessive vascular adhesionJCI Insight, 2006